Fig. 2
From: Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
A Wide-field fundus photos of a patient with a history of central nervus system lymphoma and primary vitreoretinal lymphoma involving the subretinal and subretinal pigment epithelium tissue layers with B fundus photo demonstrating disease regression one month after intravitreal methotrexate. C Optical coherence tomography scan shows lesion under the retinal pigment epithelium prior to intravitreal methotrexate (asterisk). D Mild outer retinal irregularities and RPE changes are observed following treatment